CIK: 0001381843 · Show all filings
Period: Q4 2016 (← Previous) (Next →)
Filing Date: Jan 24, 2017
Total Value ($000): $108,536 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SUPN | SUPERNUS PHARMACEUTICALS INC | 538,241 | $13,591 | 12.5% | $19.14 | +16.8% | COM | 868459108 |
| ANIK | ANIKA THERAPEUTICS INC | 175,967 | $8,615 | 7.9% | $38.50 | +20.1% | COM | 035255108 |
| CAH | CARDINAL HEALTH INC | 117,800 | $8,478 | 7.8% | $60.64 | -8.8% | COM | 14149Y108 |
| CRL | CHARLES RIV LABS INTL INC | 111,112 | $8,466 | 7.8% | $63.72 | +19.2% | COM | 159864107 |
| COR | AMERISOURCEBERGEN CORP | 107,000 | $8,366 | 7.7% | $60.96 | -3.6% | COM | 03073E105 |
| — | TARO PHARMACEUTICAL INDS LTD | 78,905 | $8,306 | 7.7% | $143.25 | — | SHS | M8737E108 |
| ELV | ANTHEM INC | 56,300 | $8,094 | 7.5% | $117.97 | +0.5% | COM | 036752103 |
| GILD | GILEAD SCIENCES INC | 113,000 | $8,092 | 7.5% | $53.19 | 0.0% | COM | 375558103 |
| MRK | MERCK & CO INC | 136,100 | $8,012 | 7.4% | $36.03 | +22.4% | COM | 58933Y105 |
| MCK | MCKESSON CORP | 57,000 | $8,006 | 7.4% | $136.84 | 0.0% | COM | 58155Q103 |
| — | TRIPLE-S MGMT CORP | 364,156 | $7,538 | 6.9% | $19.84 | — | CL B | 896749108 |
| — | SYNERON MEDICAL LTD | 706,107 | $5,931 | 5.5% | $8.40 | — | ORD SHS | M87245102 |
| — | GNC HLDGS INC | 422,955 | $4,669 | 4.3% | $30.08 | — | COM CL A | 36191G107 |
| ATEC | ALPHATEC HOLDINGS INC | 426,855 | $1,370 | 1.3% | $5.42 | 0.0% | COM NEW | 02081G201 |
| ICCC | IMMUCELL CORP | 168,323 | $1,002 | 0.9% | $5.29 | +15.0% | COM PAR $0.10 | 452525306 |